These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 32623215)
1. The efficacy and safety of radiotherapy with adjuvant temozolomide for glioblastoma: A meta-analysis of randomized controlled studies. Wang Y; Feng Y Clin Neurol Neurosurg; 2020 Sep; 196():105890. PubMed ID: 32623215 [TBL] [Abstract][Full Text] [Related]
2. Adjuvant Temozolomide for the Treatment of Glioblastoma: A Meta-analysis of Randomized Controlled Studies. Zhao Y; Wu J; Shi L Clin Neuropharmacol; 2021 Jul-Aug 01; 44(4):132-137. PubMed ID: 34039842 [TBL] [Abstract][Full Text] [Related]
3. Temozolomide for high grade glioma. Hart MG; Garside R; Rogers G; Stein K; Grant R Cochrane Database Syst Rev; 2013 Apr; 2013(4):CD007415. PubMed ID: 23633341 [TBL] [Abstract][Full Text] [Related]
4. Letter to the editor regarding "The efficacy and safety of radiotherapy with adjuvant temozolomide for glioblastoma: A meta-analysis of randomized controlled studies". Yang L; Ye Z; Huang Q Clin Neurol Neurosurg; 2023 Apr; 227():107666. PubMed ID: 36870087 [No Abstract] [Full Text] [Related]
5. Short-term radiotherapy followed by adjuvant chemotherapy in poor-prognosis patients with glioblastoma. Muni R; Minniti G; Lanzetta G; Caporello P; Frati A; Enrici MM; Marchetti P; Enrici RM Tumori; 2010; 96(1):60-4. PubMed ID: 20437859 [TBL] [Abstract][Full Text] [Related]
6. A meta-analysis of temozolomide versus radiotherapy in elderly glioblastoma patients. Yin AA; Cai S; Dong Y; Zhang LH; Liu BL; Cheng JX; Zhang X J Neurooncol; 2014 Jan; 116(2):315-24. PubMed ID: 24178440 [TBL] [Abstract][Full Text] [Related]
7. The evolution of chemoradiation for glioblastoma: a modern success story. Mirimanoff RO Curr Oncol Rep; 2006 Jan; 8(1):50-3. PubMed ID: 16464403 [TBL] [Abstract][Full Text] [Related]
8. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. Stupp R; Mason WP; van den Bent MJ; Weller M; Fisher B; Taphoorn MJ; Belanger K; Brandes AA; Marosi C; Bogdahn U; Curschmann J; Janzer RC; Ludwin SK; Gorlia T; Allgeier A; Lacombe D; Cairncross JG; Eisenhauer E; Mirimanoff RO; ; N Engl J Med; 2005 Mar; 352(10):987-96. PubMed ID: 15758009 [TBL] [Abstract][Full Text] [Related]
9. Accelerated hyperfractionated radiochemotherapy with temozolomide is equivalent to normofractionated radiochemotherapy in a retrospective analysis of patients with glioblastoma. Lewitzki V; Klement RJ; Kosmala R; Lisowski D; Flentje M; Polat B Radiat Oncol; 2019 Dec; 14(1):227. PubMed ID: 31831026 [TBL] [Abstract][Full Text] [Related]
10. Outcome of newly diagnosed glioblastoma patients treated by radiotherapy plus concomitant and adjuvant temozolomide: a long-term analysis. Erpolat OP; Akmansu M; Goksel F; Bora H; Yaman E; Büyükberber S Tumori; 2009; 95(2):191-7. PubMed ID: 19579865 [TBL] [Abstract][Full Text] [Related]
11. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Stupp R; Hegi ME; Mason WP; van den Bent MJ; Taphoorn MJ; Janzer RC; Ludwin SK; Allgeier A; Fisher B; Belanger K; Hau P; Brandes AA; Gijtenbeek J; Marosi C; Vecht CJ; Mokhtari K; Wesseling P; Villa S; Eisenhauer E; Gorlia T; Weller M; Lacombe D; Cairncross JG; Mirimanoff RO; ; Lancet Oncol; 2009 May; 10(5):459-66. PubMed ID: 19269895 [TBL] [Abstract][Full Text] [Related]
12. [Temozolomide in patients with a glioblastoma multiforme: new developments]. Bromberg JE; Postma TJ Ned Tijdschr Geneeskd; 2005 Jun; 149(25):1376-8. PubMed ID: 15997689 [TBL] [Abstract][Full Text] [Related]
14. The efficacy of hypofractionated radiotherapy (HFRT) with concurrent and adjuvant temozolomide in newly diagnosed glioblastoma: A meta-analysis. Guo L; Li X; Chen Y; Liu R; Ren C; Du S Cancer Radiother; 2021 Apr; 25(2):182-190. PubMed ID: 33436285 [TBL] [Abstract][Full Text] [Related]
15. Prognostic implications of the subcellular localization of survivin in glioblastomas treated with radiotherapy plus concomitant and adjuvant temozolomide. Saito T; Sugiyama K; Takeshima Y; Amatya VJ; Yamasaki F; Takayasu T; Nosaka R; Muragaki Y; Kawamata T; Kurisu K J Neurosurg; 2018 Mar; 128(3):679-684. PubMed ID: 28430038 [TBL] [Abstract][Full Text] [Related]
16. A Systematic Review and Meta-Analysis on the Effectiveness of Radiotherapy and Temozolomide Treatment With or Without Bevacizumab in Patients With Glioblastoma Multiforme. Yang F; Wang L; Zhao W; Wang S; Li J; Sun A; Wang M; Wang Z; Chen Z; Heng X Neurol India; 2024 Jul; 72(4):700-707. PubMed ID: 39216020 [TBL] [Abstract][Full Text] [Related]
17. Temozolomide for high grade glioma. Hart MG; Grant R; Garside R; Rogers G; Somerville M; Stein K Cochrane Database Syst Rev; 2008 Oct; (4):CD007415. PubMed ID: 18843749 [TBL] [Abstract][Full Text] [Related]
18. Effects of Temozolomide and Radiotherapy on Brain Metastatic Tumor: A Systematic Review and Meta-Analysis. Ma W; Li N; An Y; Zhou C; Bo C; Zhang G World Neurosurg; 2016 Aug; 92():197-205. PubMed ID: 27072333 [TBL] [Abstract][Full Text] [Related]
19. The Efficacy and Safety of Adjuvant Lomustine to Chemotherapy for Recurrent Glioblastoma: A Meta-analysis of Randomized Controlled Studies. Fu X; Shi D; Feng Y Clin Neuropharmacol; 2022 Nov-Dec 01; 45(6):162-167. PubMed ID: 36383914 [TBL] [Abstract][Full Text] [Related]
20. The added value of concurrently administered temozolomide versus adjuvant temozolomide alone in newly diagnosed glioblastoma. Sher DJ; Henson JW; Avutu B; Hochberg FH; Batchelor TT; Martuza RL; Barker FG; Loeffler JS; Chakravarti A J Neurooncol; 2008 May; 88(1):43-50. PubMed ID: 18231723 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]